NASDAQ:KRYS
Krystal Biotech, Inc.
- Stock
Last Close
210.69
26/07 20:00
Market Cap
5.52B
Beta: 0.85
Volume Today
222.62K
Avg: 203.48K
PE Ratio
−105.15
PFCF: −26.48
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -1.15M - | -7.92M 588.70% | -10.89M 37.49% | -19.09M 75.30% | -32.17M 68.52% | -69.57M 116.28% | -139.97M 101.20% | 10.93M 107.81% | |
depreciation and amortization | 2K - | 23K 1,050% | 141K 513.04% | 748K 430.50% | 1.85M 147.46% | 2.77M 49.59% | 4.05M 46.44% | 5.01M 23.48% | |
deferred income tax | 46.62M - | ||||||||
stock based compensation | 33K - | 246K 645.45% | 792K 221.95% | 1.24M 56.44% | 3.27M 164.08% | 15.32M 368.18% | 33.23M 116.92% | 39.93M 20.17% | |
change in working capital | -203K - | 498K 345.32% | 511K 2.61% | -1.68M 428.57% | 928K 155.27% | 2.05M 121.12% | 2.81M 36.99% | -37.88M 1,447.63% | |
accounts receivables | -42.04M - | ||||||||
inventory | -4.47M - | ||||||||
accounts payables | 42K - | 133K 216.67% | 112K 15.79% | -199K 277.68% | 783K 493.47% | 712K 9.07% | -1.25M 276.12% | -101K 91.95% | |
other working capital | -245K - | 365K 248.98% | 399K 9.32% | -1.48M 470.93% | 145K 109.80% | 1.34M 824.14% | 4.07M 203.36% | 8.73M 114.86% | |
other non cash items | 7K - | 3.26M 46,514.29% | 67K - | 33K 50.75% | 1.49M 4,421.21% | -690K 146.25% | -153.41M 22,133.33% | ||
net cash provided by operating activities | -1.31M - | -3.89M 196.72% | -9.45M 142.80% | -18.71M 98.13% | -26.08M 39.38% | -47.94M 83.79% | -100.57M 109.79% | -88.80M 11.70% | |
investments in property plant and equipment | -15K - | -210K 1,300% | -2.23M 963.81% | -6.40M 186.44% | -14.84M 131.96% | -68.34M 360.39% | -52.98M 22.47% | -11.80M 77.73% | |
acquisitions net | |||||||||
purchases of investments | -8.09M - | -9.07M 12.13% | -3.21M 64.66% | -190.46M 5,842.65% | -318.78M 67.37% | -508.78M 59.60% | |||
sales maturities of investments | 10.50M - | 6.87M 34.61% | 32.03M 366.40% | 257.68M 704.54% | 503.21M 95.29% | ||||
other investing activites | 100M - | ||||||||
net cash used for investing activites | -15K - | -210K 1,300% | -10.32M 4,815.71% | -4.97M 51.87% | -11.18M 125.06% | -226.77M 1,928.17% | -114.08M 49.69% | 82.64M 172.44% | |
debt repayment | |||||||||
common stock issued | 100K - | 42.47M 42,369% | 73.85M 73.88% | 107.53M 45.61% | 118.02M 9.76% | 355.64M 201.35% | 36.00M 89.88% | 203.50M 465.34% | |
common stock repurchased | |||||||||
dividends paid | |||||||||
other financing activites | 3.15M - | 9.30M 195.30% | -7.96M - | -649K 91.85% | -749K 15.41% | ||||
net cash used provided by financing activities | 3.25M - | 51.77M 1,493.35% | 73.85M 42.65% | 107.53M 45.61% | 118.02M 9.76% | 347.69M 194.60% | 35.35M 89.83% | 202.75M 473.60% | |
effect of forex changes on cash | -41K - | -156K 280.49% | |||||||
net change in cash | 1.92M - | 47.67M 2,378.84% | 54.08M 13.45% | 83.84M 55.04% | 80.75M 3.68% | 72.98M 9.63% | -179.35M 345.76% | 196.43M 209.52% | |
cash at beginning of period | 1.92M - | 49.59M 2,478.84% | 103.67M 109.05% | 187.51M 80.88% | 268.27M 43.07% | 341.25M 27.20% | 161.90M 52.56% | ||
cash at end of period | 1.92M - | 49.59M 2,478.84% | 103.67M 109.05% | 187.51M 80.88% | 268.27M 43.07% | 341.25M 27.20% | 161.90M 52.56% | 358.33M 121.33% | |
operating cash flow | -1.31M - | -3.89M 196.72% | -9.45M 142.80% | -18.71M 98.13% | -26.08M 39.38% | -47.94M 83.79% | -100.57M 109.79% | -88.80M 11.70% | |
capital expenditure | -15K - | -210K 1,300% | -2.23M 963.81% | -6.40M 186.44% | -14.84M 131.96% | -68.34M 360.39% | -52.98M 22.47% | -11.80M 77.73% | |
free cash flow | -1.33M - | -4.10M 209.20% | -11.68M 184.85% | -25.11M 115.02% | -40.93M 62.97% | -116.27M 184.11% | -153.55M 32.06% | -100.60M 34.48% |
All numbers in USD (except ratios and percentages)